Samsung Electronics Co. Ltd (SMSN)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 4,288.00 |
|---|---|
| 52-week range | 1,575.00 – 6,055.00 |
| Return, 1 month / 3 months | −15.3% / +5.3% |
| Return, 1 year / 3 years | +143.1% / +265.1% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 45 |
| Volatility (1 year) | 65.9% |
| Worst drawdown (1 year) | -38.2% |
| Average daily value traded | 81.42M USD |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Samsung Electronics is a South Korean technology company that makes consumer electronics and the components inside them. It produces smartphones, televisions, monitors, home appliances and memory chips, and it supplies semiconductors and display panels to other manufacturers. Its customers include everyday consumers who buy its devices and businesses that use its components. The company is based in Suwon, South Korea, and its products are sold in markets around the world.
On this site Samsung Electronics Co. Ltd appears as a stock on the London Stock Exchange (UK), code SMSN, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Samsung Electronics Co. Ltd (SMSN) trades on the London Stock Exchange in UK. It last closed at USD 4,288.00 on 27 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 1,451 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 143.1% and over the last three months it rose 5.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.2% | ||
| From 52-week high | -28.7% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 5.3% | ||
| 6-month return | 13.3% | ||
| 12-month return, skipping the last month | 187.2% | ||
| Stability (higher is calmer) | 25 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 65.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.2% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 81.42M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 46 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 6 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +6.1% |
|---|---|
| 1 month | −15.3% |
| 3 months | +5.3% |
| 6 months | +13.3% |
| 1 year | +143.1% |
| 3 years | +265.1% |
| 5 years | +216.7% |
Signals
| 50-day / 200-day average | 4,678.92 / 4,155.90 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 202.99 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Jun 2026 | USD 6.7794 |
| 30 Mar 2026 | USD 6.1713 |
| 30 Dec 2025 | USD 9.5432 |
| 29 Sep 2025 | USD 6.3038 |
| 27 Jun 2025 | USD 6.5532 |
| 28 Mar 2025 | USD 6.5624 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.